#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15854	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2131	739.8	0	.	n	.	0	A69G	SNP	69	69	A	316	316	G	924	G,A	843,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15854	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2131	739.8	0	.	n	.	0	C1450T	SNP	1450	1450	C	1697	1697	T	840	T,C	780,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15854	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2131	739.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1431	1431	C	964	C,T	896,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28786	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3494	820.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1550	1550	A	1021	A,G	947,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28786	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3494	820.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2184	2184	C	967	C,T	873,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28786	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3494	820.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2258	2258	A	913	A	866	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28786	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3494	820.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2810	2810	C	966	C	903	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_U_01433c	folP.WHO_U_01433c	1	1	539	2130	folP	852	852	99.88	folP.l15.c17.ctg.1	1536	138.2	0	.	p	.	0	E151K	NONSYN	451	453	GAA	774	776	AAA	203;204;204	A;A;A	186;187;187	.	.
folP.WHO_U_01433c	folP.WHO_U_01433c	1	1	539	2130	folP	852	852	99.88	folP.l15.c17.ctg.1	1536	138.2	1	SNP	p	R228S	1	.	.	682	684	AGC	1005	1007	AGC	242;247;246	A;G;C	228;232;230	folP.WHO_U_01433c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5636	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3374	166.4	0	.	p	.	0	K261del	DEL	781	781	A	1004	1004	A	193	A	177	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5636	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3374	166.4	1	SNP	p	S91F	0	.	.	271	273	TCC	494	496	TCC	192;190;194	T;C;C	174;173;177	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5636	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3374	166.4	1	SNP	p	D95N	0	.	.	283	285	GAC	506	508	GAC	193;191;189	G;A;C	180;176;173	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5636	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3374	166.4	1	SNP	p	D95G	0	.	.	283	285	GAC	506	508	GAC	193;191;189	G;A;C	180;176;173	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1686	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1356	123.7	1	SNP	p	G45D	0	.	.	133	135	GGC	423	425	GGC	195;192;192	G;G;C,T	184;180;180,1	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	880	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	991	88.0	0	.	n	.	0	A197.	DEL	197	197	A	581	581	A	201	A	186	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5420	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3056	176.9	1	SNP	p	D86N	0	.	.	256	258	GAC	645	647	GAC	230;229;231	G;A;C	212;209;214	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5420	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3056	176.9	1	SNP	p	S87I	0	.	.	259	261	AGT	648	650	AGT	231;233;235	A,G;G;T	212,1;216;212	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5420	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3056	176.9	1	SNP	p	S87R	0	.	.	259	261	AGT	648	650	AGT	231;233;235	A,G;G;T	212,1;216;212	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5420	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3056	176.9	1	SNP	p	S87W	0	.	.	259	261	AGT	648	650	AGT	231;233;235	A,G;G;T	212,1;216;212	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5420	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3056	176.9	1	SNP	p	S88P	0	.	.	262	264	TCC	651	653	TCC	234;232;231	T;C;C	213;207;210	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4700	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2682	174.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1504	1506	GGC	227;227;225	G;G;C	208;206;206	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	4316	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2237	191.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1158	1160	GCA	240;241;241	G;C;A	220;219;222	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4316	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2237	191.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1161	1163	ATC	241;244;245	A;T;C	223;220;224	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4316	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2237	191.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1173	1175	GTG	239;238;238	G;T;G	223;219;223	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4316	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2237	191.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1173	1175	GTG	239;238;238	G;T;G	223;219;223	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4316	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2237	191.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1677	1679	ACC	203;201;203	A;C;C	185;185;190	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4316	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2237	191.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1731	1733	GCG	193;195;196	G;C;G,T,C	175;159;170,1,1	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4316	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2237	191.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1731	1733	GCG	193;195;196	G;C;G,T,C	175;159;170,1,1	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4316	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2237	191.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1854	1856	GGC	163;162;163	G,C;G,A;C	147,1;145,1;148	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4316	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2237	191.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1863	1865	GGC	171;172;171	G;G;C	152;157;152	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4316	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2237	191.5	1	SNP	p	L552S	0	.	.	1654	1656	CTG	1881	1883	CTG	161;162;160	C,G;T;G	121,4;120;128	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6488	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	3145	205.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1699	1701	CCG	246;248;249	C;C;G	222;230;226	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2268	porA	1146	1146	99.65	porA.l15.c30.ctg.1	1877	120.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	586	586	C	170	C	154	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3088	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1417	215.4	0	.	p	.	0	N38E	NONSYN	112	114	AAT	348	350	GAA	277;278;277	G;A;A	254;257;256	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3088	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1417	215.4	0	.	p	.	0	N134D	NONSYN	400	402	AAT	636	638	GAT	268;266;267	G;A;T	243;243;244	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3088	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1417	215.4	0	.	p	.	0	P175S	NONSYN	523	525	CCA	759	761	TCA	278;278;281	T;C;A	259;259;261	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3088	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1417	215.4	0	.	p	.	0	A218V	NONSYN	652	654	GCC	888	890	GTC	251;248;247	G;T;C	234;235;232	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3088	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1417	215.4	0	.	p	.	0	F222S	NONSYN	664	666	TTT	900	902	TCT	255;251;252	T;C;T	238;239;241	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3088	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1417	215.4	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1218	1220	GCA	237;236;233	G;C;A	219;218;212	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3088	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1417	215.4	1	SNP	p	G120K	1	.	.	358	360	AAG	594	596	AAG	263;267;266	A;A;G	245;248;246	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3088	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1417	215.4	1	SNP	p	A121D	1	.	.	361	363	GAC	597	599	GAC	265;264;261	G;A;C	245;244;241	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3088	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1417	215.4	1	SNP	p	D121N	0	.	.	361	363	GAC	597	599	GAC	265;264;261	G;A;C	245;244;241	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	11532	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4898	235.0	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2038	2040	AAT	258;262;260	A;A;T	237;240;237	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1256	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1073	116.3	1	SNP	p	V57M	1	.	.	169	171	ATG	557	559	ATG	248;252;252	A;T,C;G,A	233;234,1;234,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
